Finanzwire Finanzwire
Basculer en Français
11138 Companies
245327 Keywords
173322 Articles
132291 Press releases
Headlines Articles Press releases Americord Remove
  1. Home
  2. Companies
  3. Americord
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/23/2024 at 16:30, 2 years 7 months ago

    Americord makes breakthrough in treating Motor Neuron Disease with cord blood stem cells

    Americord Stem Cells Cord Blood Motor Neuron Disease Treatment
  • PRESS RELEASE

    published on 02/23/2024 at 16:30, 2 years 7 months ago

    Americord Releases Cord Blood Stem Cells for Treatment of Motor Neuron Disease

    Americord releases cord blood stem cells for the treatment of motor neuron disease in India, highlighting the therapeutic potential of stem cells in healthcare
    Healthcare Americord Motor Neuron Disease Treatment Cord Blood Stem Cells
    Logo of Americord
  • PRESS RELEASE

    published on 12/06/2023 at 15:00, 2 years 9 months ago

    Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey

    Americord, a leader in the biobanking industry, has relocated its laboratory from New York City to a state-of-the-art facility in Somerset, New Jersey, marking a milestone in advancing research, product quality, and growth opportunities
    Americord Biobanking Laboratory Relocation Research Somerset New Jersey
    Logo of Americord
Accesswire
  • Published on 10/06/2026 at 14:31, 14 minutes ago

    Worksport (Nasdaq: WKSP) Books $2.92M August Orders; Annualized Order Run Rate Reaches $35M

  • Published on 10/06/2026 at 13:30, 1 hour 15 minutes ago

    Golden Minerals Commences Drilling at its Desierto Property, Argentina

  • Published on 10/06/2026 at 13:00, 1 hour 45 minutes ago

    INEO to Present at LD Micro 20th Annual Main Event on October 21, 2026

  • Published on 10/06/2026 at 12:30, 2 hours 15 minutes ago

    Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock

  • Published on 10/06/2026 at 12:00, 2 hours 45 minutes ago

    Banyan Gold Intersects 1.88 g/t Gold over 17.9 Metres in the Gap Between Airstrip and Powerline, and Identifies High-Grade Gold in Airstrip Footwall at AurMac, Yukon, Canada

View all ACCESSWIRE
EQS Group
  • Published on 10/06/2026 at 14:37, 7 minutes ago

    thyssenkrupp nucera Establishes Its First Company-Operated Electrolyzer Cell Assembly Hub in Europe

  • Published on 10/06/2026 at 14:05, 39 minutes ago

    Intellias launches Agentic ServiceOps bringing governed AI agents to service desk and infrastructure

  • Published on 10/06/2026 at 14:05, 39 minutes ago

    Cellex Cell Professionals Surpasses 10,000 Autologous ATMP Manufacturing Batches

  • Published on 10/06/2026 at 14:00, 44 minutes ago

    Original-Research: BASF SE (von Parmantier & Cie. GmbH): Buy

  • Published on 10/06/2026 at 13:55, 49 minutes ago

    DB Regio Rail Division digitalises its employee processes with IVU.pad

View all EQS
Les Echos
  • Published on 10/05/2026 at 22:12, 16 hours 32 minutes ago

    AXA - Elimination of the dilutive impact of Shareplan 2026

  • Published on 10/05/2026 at 18:13, 20 hours 32 minutes ago

    Disclosure of shares outstanding and voting rights - 05.10.2026

  • Published on 10/05/2026 at 17:45, 21 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 10/05/2026 at 17:45, 21 hours ago

    Declaration of voting rights at the end of September 2026

  • Published on 10/05/2026 at 17:45, 21 hours ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy